Skip to main content
[Preprint]. 2024 Jun 3:rs.3.rs-4244833. [Version 1] doi: 10.21203/rs.3.rs-4244833/v1

Figure 3. Clinical characterization of complete responders to 2141-V11.

Figure 3.

a, Representative photographs of the cutaneous lesions of patient 06 that achieve CR to 2141-V11. Images of injected (red arrows) and non-injected target lesions (green arrows) were obtained at baseline and at indicated cycle and day timepoints. b, Representative photographs of patient 14 that achieve complete response to 2141-V11. Images of injected (red arrows) and non-injected target lesions (green arrows) were obtained at baseline and at indicated post-treatment timepoints. c, Radiographic assessment of non-target axillary lymph nodes and liver metastases were obtained at baseline and after treatment with 2141-V11 in patient 14. d, Tumor markers of patient 14 before and after treatment with 2141-V11, red arrows indicate time of treatment initiation. Dashed lines indicate normal values of each tumor marker. C: Cycle. D: Day.